155 related articles for article (PubMed ID: 33856447)
1. Familial patterns of hematologic precursors.
Landgren O; Maura F
Blood; 2021 Apr; 137(15):1992-1993. PubMed ID: 33856447
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in hematology: introduction.
Beris P
Semin Hematol; 2013 Jan; 50(1):15. PubMed ID: 23507480
[No Abstract] [Full Text] [Related]
3. [Evolution of a double agent: cytogenetics in hematology].
Berger R
Pathol Biol (Paris); 2003 Aug; 51(6):305-6. PubMed ID: 12927886
[No Abstract] [Full Text] [Related]
4. [Fluorescence in situ hybridization in hematology].
Milosević I; Popović S; Urosević I
Vojnosanit Pregl; 2012 Nov; 69(11):986-93. PubMed ID: 23311251
[No Abstract] [Full Text] [Related]
5. A special issue on modern genomics in diagnostic haematology.
Br J Haematol; 2021 Sep; 194(5):801-802. PubMed ID: 34463970
[No Abstract] [Full Text] [Related]
6. [Hematology: large steps followed by a time of small steps].
Fehr J
Schweiz Med Wochenschr; 1998 Dec; 128(51-52):2034-7. PubMed ID: 10025003
[No Abstract] [Full Text] [Related]
7. [Minimal residual disease in hematology].
Rák K
Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
[No Abstract] [Full Text] [Related]
8. [Experimental hematology bridging the gap between laboratory and clinic: hope of hematology].
Chen Z; Chen SJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):1-21. PubMed ID: 18315892
[TBL] [Abstract][Full Text] [Related]
9. American Society of Hematology--49th Annual Meeting and Exposition. Part 1. 7-11 December 2007, Atlanta, GA, USA.
Murch L; Veryard C
IDrugs; 2008 Feb; 11(2):71-2. PubMed ID: 18240084
[No Abstract] [Full Text] [Related]
10. [Research on demethylation therapy for hematology malignancy].
Shen JZ; Zhou HR
Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):355-6. PubMed ID: 16780731
[No Abstract] [Full Text] [Related]
11. DNA damage response and disorders with hematology, oncology and immunology.
Mizutani S
Int J Hematol; 2017 Sep; 106(3):326-327. PubMed ID: 28699030
[No Abstract] [Full Text] [Related]
12. [Epigenetic regulators as novel therapeutic targets in hematology/oncology].
Mahlknecht U; Hoelzer D
Dtsch Med Wochenschr; 2003 Nov; 128(46):2423-6. PubMed ID: 14614656
[No Abstract] [Full Text] [Related]
13. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
[TBL] [Abstract][Full Text] [Related]
14. Ethical considerations in genomic testing for hematologic disorders.
Marron JM; Joffe S
Blood; 2017 Jul; 130(4):460-465. PubMed ID: 28600340
[TBL] [Abstract][Full Text] [Related]
15. The GATA factor revolution in hematology.
Katsumura KR; Bresnick EH;
Blood; 2017 Apr; 129(15):2092-2102. PubMed ID: 28179282
[TBL] [Abstract][Full Text] [Related]
16. Bracha Ramot (1927-2006).
Ben-Bassat I; Raanani P
Blood Cells Mol Dis; 2007; 39(2):135-9. PubMed ID: 17957832
[No Abstract] [Full Text] [Related]
17. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
Mecucci C; Falzetti D; La Starza R
Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
[No Abstract] [Full Text] [Related]
18. [Designer drugs and their rational use in clinical hematology].
Bukh A; D'Amore FA; Gimsing P; Hasselbalch HC; Johnsen HE; Kerndrup GB; Kristensen JS; Peterslund NA; ;
Ugeskr Laeger; 2005 May; 167(20):2180-3. PubMed ID: 15987079
[No Abstract] [Full Text] [Related]
19. Abstracts of the American Society of Pediatric Hematology/Oncology (ASPHO) 26th Annual Meeting. Miami, Florida, USA. April 24-27, 2013.
Pediatr Blood Cancer; 2013 Jun; 60 Suppl 2():S1-105. PubMed ID: 23596123
[No Abstract] [Full Text] [Related]
20. XVth Congress of the French Society of Hematology. Paris, France, February 9-10, 1996. Abstracts.
Hematol Cell Ther; 1996 Feb; 38(1):1-158. PubMed ID: 8968415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
